Atlas Trials

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT02633176 · UNKNOWN

Trial details

NCT number
NCT02633176
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2015-01-01
Primary completion
2023-01-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.